Lack of FDA Approval for Genetic Test Kit Halts Sales

The pharmacy chain Walgreen said Wednesday that it will hold off on selling genetic testing kits made by San Diego-based Pathway Genomics after FDA said the kits could not be sold without regulatory approval. The kits were expected to be sold for $20 and for additional fees would identify a person's risks for certain diseases, mutations or adverse drug reactions. Pathway Genomics said it is communicating with FDA about the kit.

• "Genetic Testing Kit Won't Go on Market" (Darcé, San Diego Union-Tribune, 5/12).
• "Walgreens Delays Selling Personal Genetic Test Kit" (Pollack, New York Times, 5/12).
• "Walgreen Won't Sell Genetic Test Until Maker Works Out Issues With FDA" (Corbett Dooren, Wall Street Journal, 5/12).